If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVp Regulatory News (VP.)

Share Price Information for Vp (VP.)

Share Price is delayed by 15 minutes
Get Live Data
480.00    0.00 (0.00%)
Bid:
486.00
Ask:
494.00
Spread: 8.00 (1.646%)
Market Cap: £189.67m
VP. Live PriceLast checked at - London Stock Exchange

Intraday Vp Share Chart

Director/PDMR Shareholding

8 Aug 2024 13:06

RNS Number : 7756Z
Vp PLC
08 August 2024
Β 

Immediate Release 28 July 2024

Vp plc

('the Company')

Β 

Grant of SAYE Options and PDMR Dealing

Β 

Vp plc announces that on 26 July 2024, it granted 1,344 options over new ordinary shares ofΒ 5 penceΒ each ("Ordinary Shares") to certain employees and directors of the Group under the Vp plc Save As You Earn scheme ("SAYE Scheme").

Β 

Participation in the SAYE Scheme has been made available to all employees of the Company who satisfy certain eligibility criteria. The following directors and persons discharging managerial responsibility ("PDMRs") of the Company have elected to participate in the SAYE Scheme and their options are included in the total figures above.Β 

Β 

Β 

Name

Title

Number of Ordinary Shares over which options granted

Exercise price

Anna Bielby

Chief Executive Officer

Β 

672

552p

Keith Winstanley

Chief Financial Officer

672

552p

Β 

The options vest after three years, subject to continued employment with the Group, and are exercisable at a price of 552 pence per share, calculated in accordance with the rules of the SAYE Scheme representing a discount of 20% to the mid-market closing price on 27 June 2024, being the last practicable day prior to the invitation made to all eligible employees on 28 June 2024.

Β 

The below notifications made in accordance with the requirements of the UK Market Abuse Regulation provide further detail:

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Anna Bielby

2.

Reason for the notification

a)

PositionΒ / status

Chief Executive Officer (Director and PDMR)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Vp plc

b)

LEI

213800TBQKKQR7UXZP80

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument,Β type of instrument

Options over ordinary shares ofΒ 5 penceΒ each

b)

Identification code

ISIN: GB0009286963

c)

Nature of the transaction

Grant of SAYE Options

d)

Price(s) and volume(s)

Β 

Price

Volume

552p

672

e)

Aggregated information

- Volume

- Price

N/A - Single transaction

f)

Date of the transaction

26 July 2024

g)

Place of the transaction

Outside of a trading venue

Β 

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Keith Winstanley

2.

Reason for the notification

a)

PositionΒ / status

Chief Financial Officer (Director and PDMR)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Vp plc

b)

LEI

213800TBQKKQR7UXZP80

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument,Β type of instrument

Options over ordinary shares ofΒ 5 penceΒ each

b)

Identification code

ISIN: GB0009286963

c)

Nature of the transaction

Grant of SAYE Options

d)

Price(s) and volume(s)

Β 

Price

Volume

552p

672

e)

Aggregated information

- Volume

- Price

N/A - Single transaction

f)

Date of the transaction

26 July 2024

g)

Place of the transaction

Outside of a trading venue

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHQKFBKBBKDPFK
Date   Source Headline
6th Jul 20267:00 amRNS-RMello Investor Presentation
18th Jun 20262:05 pmRNSDirector Declaration
10th Jun 20267:00 amRNSFinal Results
29th May 20267:00 amRNSNotice of Results & Investor Presentation
17th Apr 20267:00 amRNSTrading Update
30th Mar 20263:15 pmRNSDirector Share Purchase
19th Mar 20267:00 amRNSDirector Share Purchase
3rd Mar 20263:30 pmRNSDirector Share Purchase
11th Feb 20267:00 amRNSTrading Update
2nd Feb 20267:00 amRNSCEO Transition Update
19th Dec 20257:00 amRNSCEO Appointment
19th Dec 20257:00 amRNSCEO Appointment
27th Nov 20257:00 amRNSInterim Results
17th Oct 20257:00 amRNSNotice of Results & Investor Presentation
10th Oct 20257:00 amRNSTrading Update
24th Sep 20257:00 amRNSCEO succession
1st Aug 202511:00 amRNSNotification of Major Holdings
30th Jul 20254:45 pmRNSGrant of SAYE Options and PDMR Dealing
23rd Jul 20253:00 pmRNSResults of Annual General Meeting
23rd Jul 20257:00 amRNSAGM Statement
21st Jul 20255:17 pmRNSGrant of Long Term Incentive Plan Awards
21st Jul 20255:16 pmRNSGrant of Long Term Incentive Plan Awards
21st Jul 20255:15 pmRNSGrant of Long Term Incentive Plan Awards
30th Jun 20257:00 amRNSDirectorate Change
24th Jun 20252:30 pmRNSAnnual Report and Notice of AGM
11th Jun 20257:00 amRNSFinal Results
9th Jun 20253:00 pmRNSPCA Dealing
27th May 20257:00 amRNSNotice of Results & Investor Presentation
15th Apr 20257:00 amRNSTrading Update
27th Mar 20259:00 amRNSDirector Declaration
6th Feb 20252:31 pmRNSDirector Share Purchase
6th Feb 20252:30 pmRNSDirector Share Purchase
30th Jan 20257:00 amRNSAppointment of Non-Executive Director
29th Jan 20254:00 pmRNSDirector Share Purchase
29th Jan 20254:00 pmRNSDirector Share Purchase
23rd Jan 202512:00 pmRNSDirector Share Purchase
22nd Jan 202512:00 pmRNSDirector Share Purchase
17th Jan 20251:45 pmRNSDirector Share Purchase
9th Jan 20253:00 pmRNSAnnex DTR3
26th Nov 20247:00 amRNSInterim Results
30th Oct 20247:00 amRNSNotice of Results & Investor Presentations
3rd Oct 20247:01 amRNSTrading Update
3rd Oct 20247:00 amRNSAcquisition of Charleville Hire and Platform Ltd
13th Aug 20244:17 pmRNSDirector/PDMR Shareholding
8th Aug 20241:06 pmRNSDirector/PDMR Shareholding
25th Jul 20243:09 pmRNSResults of Annual General Meeting
25th Jul 20247:00 amRNSAGM Statement
24th Jul 20242:27 pmRNSPDMR Dealings
24th Jul 20242:25 pmRNSPDMR Dealings
24th Jul 20242:23 pmRNSPDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.